Role of IL-33 and ST2 signalling pathway in multiple sclerosis: expression by oligodendrocytes and inhibition of myelination in central nervous system

Recent research findings have provided convincing evidence indicating a role for Interleukin-33 (IL-33) signalling pathway in a number of central nervous system (CNS) diseases including multiple sclerosis (MS) and Alzheimer’s disease. However, the exact function of IL-33 molecule within the CNS unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Allan, Debbie, Fairlie-Clarke, Karen J., Elliott, Christina, Schuh, Cornelia, Barnett, Susan C., Lassmann, Hans, Linnington, Christopher, Jiang, Hui-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960877/
https://www.ncbi.nlm.nih.gov/pubmed/27455844
http://dx.doi.org/10.1186/s40478-016-0344-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960877/
https://www.ncbi.nlm.nih.gov/pubmed/27455844
http://dx.doi.org/10.1186/s40478-016-0344-1

Ejemplares similares